Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows.
Alvotech Holdings, Oaktree Acquisition Corp. II Set Date For Extraordinary General Meeting Of Shareholders To Approve SPAC Deal As Jun. 7, 2022
Alvotech Holdings S.A. (“Alvotech S.A.”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II
Oaktree Acquisition’s Merging Partner, Alvotech Holdings, Announces Co. Enters Exclusive Global Licensing Agreement With BiosanaPharma For Co-Development Of A Proposed Biosimilar To Xolair
Alvotech Holdings S.A. ("Alvotech"), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, has entered into an exclusive global
Oaktree Acquisition Corp. II SPAC Merger Partner Alvotech Highlights Upsizing Of Oversubscribed PIPE Transaction To ~$175M
Alvotech Holdings S.A. (“Alvotech”), a leading global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp.
Biosimilar Player Alvotech To Go Public Via $2.5B Oaktree SPAC Merger
Biopharmaceutical company Alvotech Holdings SA plans to list on NASDAQ under the symbol ALVO by merging with a blank-check company…